HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study Takes Measure Of Supplement Size And Link To Swallowing Problems

Executive Summary

FDA and CDC Analysis of the 20,791 adverse event reports for vitamins, minerals and supplements from 2006 through 2015 found that 3,962, 19.1%, indicated swallowing problems and the 10 products most commonly identified in the reports all exceeded 17 mm, or 0.67 inch, in length.

You may also be interested in...



On VMS Product Delivery Format, CRN Survey Shows US Consumers Prioritize Ease Of Swallowing

Trade group recently published survey results also show although the total of US consumers using supplements in 2020, 73%, is down 4 percentage points from 2019, a substantial segment of users are taking more products.

US Wellness Market In 2019: Amarin Wins, Loses On Supplements; Gottlieb Leaves With Consumer Health Flourish

Looking look back on US wellness market developments and events in 2019, HBW Insight finds a firm that doesn’t compete in the dietary supplement sector, Amarin, made a good bit of news that affected the industry during the year. We track news across the wellness space from the past year.

Innovations In Taste, Convenience Drive Consumer Health Market Growth

Novel flavors and unique ingredients can give consumer health care marketers an edge in the marketplace, according to Datamonitor market research. Tasty products, new dosage forms and products that facilitate self-care will shape the consumer product market and drive annual 3.8% growth through 2017.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel